| Project/Area Number |
21590217
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
General anatomy (including Histology/Embryology)
|
|---|
| Research Institution | Oita University of Nursing and Health Sciences (2010-2011)
Oita University (2009) |
|---|
Principal Investigator |
SHIMODA Hiroshi 大分県立看護科学大学, 看護学部, 教授 (20274748)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
MURAKAMI Masahiro 大阪大谷大学, 薬学部, 教授 (50174280)
DAA Tsutomu 大分大学, 医学部, 准教授 (10217218)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2010: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2009: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
|---|
| Keywords | リンパ管新生 / アンジオポエチン / リンパ管誘導 / 分子形態学 / リンパ浮腫 / 中間型VEGF-C / アンジオポエチン-2 / 組織化学 / ドラッグデリバリー |
|---|
| Research Abstract |
A new lymphangiogenesis model with our own produced intermediately-processed(imp) VEGF-C, a specific lymphangiogenic factor, was established. The role of Angiopoietin(Ang)-2, another molecule regulating lymphatic vascular formation, in lymphangiogenesis was further defined using our model. On the basis of these results, we have developed a highly lymphangiogenic system with a mixture of impVEGF-C and Ang-2, and this provides a new therapeutic strategy for lymphedema.
|
